May & Baker, a pharmaceutical firm operating in Nigeria recorded a 42 percent jump in profit after tax to N1.5 billion in 2022 from N1.05 billion in 2021.
The firm’s profit before tax stood at N2.08 billion in 2022, a 42.4 percent increase from N1.46 billion in 2021.
“The poor state of
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
